Coherus Biosciences | CHRS - 무역 채권자





무역 채권자 변화 날짜
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Akebia Therapeutics USD 21.18M 11.1M 2025-12
ALKERMES USD 102.36M 5.59M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Baxter International USD 1.09B 87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Fujifilm JPY 308.06B 17.41B 2025-12
Gilead Sciences USD 715M 93M 2025-12
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Merck USD 3.86B 541M 2026-03
Myriad Genetics USD 30M 1.8M 2025-12
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xencor USD 10.83M 1.75M 2025-12
Zoetis USD 487M 77M 2025-12